CD79A and COVID-19: Several studies have shown that intranasal administration of adenovirus vector-based COVID-19 vaccines induced higher NAb levels, IgA responses and protective efficacy against SARS-CoV-2, but lower cellular immune responses, compared to intramuscular administration [18, 27, 28].